Suchergebnisse

Devil facial tumor disease (DFTD) is renowned for its successful evasion of the host immune system. Down regulation of the major histocompatabilty complex class I molecule (MHC-I) on the DFTD cells is a primary mechanism of immune escape. Immunization trials on captive Tasmanian devils have previously demonstrated that an immune response against DFTD can be induced, and that immune-mediated tumor regression can occur. However, these trials were limited by their small sample sizes. Here, we describe the results of two DFTD immunization trials on cohorts of devils prior to their wild release as part of the Tasmanian Government's Wild Devil Recovery project. 95% of the devils developed anti-DFTD antibody responses. Given the relatively large sample sizes of the trials (N = 19 and N = 33), these responses are likely to reflect those of the general devil population. DFTD cells manipulated to express MHC-I were used as the antigenic basis of the immunizations in both trials. Although the adjuvant composition and number of immunizations differed between trials, similar anti-DFTD antibody levels were obtained. The first trial comprised DFTD cells and the adjuvant combination of ISCOMATRIX™, polyIC, and CpG with up to four immunizations given at monthly intervals. This compared to the second trial whereby two immunizations comprising DFTD cells and the adjuvant combination ISCOMATRIX™, polyICLC (Hiltonol®) and imiquimod were given a month apart, providing a shorter and, therefore, more practical protocol. Both trials incorporated a booster immunization given up to 5 months after the primary course. A key finding was that devils in the second trial responded more quickly and maintained their antibody levels for longer compared to devils in the first trial. The different adjuvant combination incorporating the RNAase resistant polyICLC and imiquimod used in the second trial is likely to be responsible. The seroconversion in the majority of devils in these anti-DFTD immunization trials was remarkable, especially as DFTD is hallmarked by its immune evasion mechanisms. Microsatellite analyzes of MHC revealed that some MHC-I microsatellites correlated to stronger immune responses. These trials signify the first step in the long-term objective of releasing devils with immunity to DFTD into the wild. ; Ruth Pye, Amanda Patchett, Elspeth McLennan, Russell Thomson, Scott Carver . A. Bruce Lyons . et al.

Context Artificial intelligence algorithms are beneficial for automating the monitoring of threatened species. Devil facial tumour disease (DFTD) is an endemic disease threatening Australia's Tasmanian devil. The disease is a cancer that can be transmitted from one devil to another during social interactions. Cameras and trapping techniques have been employed to monitor the spread of the disease in the wild. The use of cameras allows for more frequent monitoring of devils than does trapping, but differentiating wounds from tumours in images is challenging, and this requires time and expertise. Aim The purpose of this work is to develop a computer vision system to assist in the monitoring of DFTD spread. Method We propose a system that involves image segmentation, feature extraction, and classification steps. U-net architecture, global average pooling layer of pre-trained Resnet-18, and support vector machine (SVM) classifiers were employed for these purposes, respectively. In total, 1250 images of 961 healthy and 289 diseased (DFTD) devils were separated into training, validation, and testing sets. Results The proposed algorithm achieved 92.4% classification accuracy for the differentiation of healthy devils from those with DFTD. Conclusion The high classification accuracy means that our method can help field workers with monitoring devils. Implications The proposed approach will allow for more frequent analysis of devils while reducing the workload of field staff. Ultimately, this automation could be expanded to other species for simultaneous monitoring at shorter intervals to facilitate broadened ecological assessments.

Devil facial tumour disease (DFTD) is a transmissible cancer devastating the Tasmanian devil (Sarcophilus harrisii) population. The cancer cell is the 'infectious' agent transmitted as an allograft by biting. Animals usually die within a few months with no evidence of antibody or immune cell responses against the DFTD allograft. This lack of anti-tumour immunity is attributed to an absence of cell surface major histocompatibility complex (MHC)-I molecule expression. While the endangerment of the devil population precludes experimentation on large experimental groups, those examined in our study indicated that immunisation and immunotherapy with DFTD cells expressing surface MHC-I corresponded with effective anti-tumour responses. Tumour engraftment did not occur in one of the five immunised Tasmanian devils, and regression followed therapy of experimentally induced DFTD tumours in three Tasmanian devils. Regression correlated with immune cell infiltration and antibody responses against DFTD cells. These data support the concept that immunisation of devils with DFTD cancer cells can successfully induce humoral responses against DFTD and trigger immune-mediated regression of established tumours. Our findings support the feasibility of a protective DFTD vaccine and ultimately the preservation of the species. ; Research support was provided by the Australian Research Council (ARC Linkage grant #LP0989727, ARC Discovery grant #DP130100715), University of Tasmania Foundation through funds raised by the Save the Tasmanian Devil Appeal. J.M.M. acknowledges fellowship support (APP1105754) and L.M.C. Program Grant funding (APP1054925) from NHMRC. J.M.M. and L.M.C. acknowledge NHMRC IRIISS (9000220) and Victorian Government Operational Infrastructure Support. Y.C. and K.B. are supported by the Australian Research Council (ARC Discovery grant #DP140103260). K.B. is funded by an ARC Future Fellowship. J.K. is supported by a Wellcome Trust programme Grant (089305).

New diseases in humans and animals have been the subject of considerable research as well as policy development and popular attention. Researchers commonly proceed on the basis of plausible assumptions about mechanisms, pathways, and dangers but seldom question the assumptions themselves. Studies in the history and sociology of science show that research trajectories are conditioned by social, political, and economic arrangements. The assumptions underlying research into three new diseases—devil facial tumor disease in Tasmanian devils, AIDS in humans, and leukemia in soft-shell clams—are examined, and dominant and alternative research programs compared. In each case, most research has assumed the disease is spread through "natural processes", while research about possible human influences has been left undone.

New diseases in humans and animals have been the subject of considerable research as well as policy development and popular attention. Researchers commonly proceed on the basis of plausible assumptions about mechanisms, pathways, and dangers but seldom question the assumptions themselves. Studies in the history and sociology of science show that research trajectories are conditioned by social, political, and economic arrangements. The assumptions underlying research into three new diseases—devil facial tumor disease in Tasmanian devils, AIDS in humans, and leukemia in soft-shell clams—are examined, and dominant and alternative research programs compared. In each case, most research has assumed the disease is spread through "natural processes", while research about possible human influences has been left undone.

Abstract Context Disease is increasingly becoming a driver of wildlife population declines and an extinction risk. Vaccines are one of the most successful health interventions in human history, but few have been tested for mitigating wildlife disease. The transmissible cancer, devil facial tumour disease (DFTD), triggered the Tasmanian devil's (Sarcophilus harrisii) inclusion on the international endangered species list. In 2016, 33 devils from a DFTD-free insurance population were given an experimental DFTD vaccination before their wild release on the Tasmanian northern coast. Aim To determine the efficacy of the vaccination protocol and the longevity of the induced responses. Method Six trapping trips took place over the 2.5 years following release, and both vaccinated and incumbent devils had blood samples and tumour biopsies collected. Key results In all, 8 of the 33 vaccinated devils were re-trapped, and six of those developed DFTD within the monitoring period. Despite the lack of protection provided by the vaccine, we observed signs of immune activation not usually found in unvaccinated devils. First, sera collected from the eight devils showed that anti-DFTD antibodies persisted for up to 2 years post-vaccination. Second, tumour-infiltrating lymphocytes were found in three of four biopsies collected from vaccinated devils, which contrasts with the 'immune deserts' typical of DFTs; only 1 of the 20 incumbent devils with DFTD had a tumour biopsy exhibiting immune-cell infiltrate. Third, immunohistochemical analysis of the vaccinated devils' tumour biopsies identified the functional immune molecules associated with antigen-presenting cells (MHC-II) and T-cells (CD3), and the immune checkpoint molecule PD-1, all being associated with anti-tumour immunity in other species. Conclusions These results correlate with our previous study on captive devils in which a prophylactic vaccine primed the devil immune system and, following DFTD challenge and tumour growth, immunotherapy induced complete tumour regressions. The field trial results presented here provide further evidence that the devil immune system can be primed to recognise DFTD cells, but additional immune manipulation could be needed for complete protection or induction of tumour regressions. Implications A protective DFTD vaccine would provide a valuable management approach for conservation of the Tasmanian devil.

Context
Conservation management relies on baseline demographic data of natural populations. For Tasmanian devils (Sarcophilus harrisii), threatened in the wild by two fatal and transmissible cancers (devil facial tumour disease DFTD: DFT1 and DFT2), understanding the characteristics of healthy populations is crucial for developing adaptive management strategies to bolster populations in the wild.

Aims
Our analysis aims to evaluate contemporary reproductive rates for wild, DFTD-free Tasmanian devil populations, and to provide a baseline with which to compare the outcome of current translocation activities.

Methods
We analysed 8 years of field-trapping data, including demographics and reproductive rates, across 2004–16, from the largest known DFTD-free remnant population at Woolnorth, Tasmania.

Key results
Surprisingly, we found a dramatic and statistically significant decline in female breeding rate when comparing data collected from 2004–2009 with data from 2014–2016. Unfortunately we do not have any data from the intermediate years. This decline in breeding rate was accompanied by a subtle but statistically significant decline in litter sizes. These changes were not associated with a change in body condition over the same period. Furthermore, we could not attribute the decline in breeding to a change in population size or sex ratio. Preliminary analysis suggested a possible association between annual breeding rate and coarse measures of environmental variation (Southern Oscillation Index), but any mechanistic associations are yet to be determined.

Conclusions
The decline in breeding rates was unexpected, so further monitoring and investigation into potential environmental and/or biological reasons for the decline in breeding rate are recommended before the arrival of DFTD at Woolnorth.

Implications
Our results provide valuable data to support the conservation management of Tasmanian devils in their native range. They also highlight the importance of continued monitoring of 'safe' populations, in the face of significant threats elsewhere.

Devil facial tumor disease (DFTD) is renowned for its successful evasion of the host immune system. Down regulation of the major histocompatabilty complex class I molecule (MHC-I) on the DFTD cells is a primary mechanism of immune escape. Immunization trials on captive Tasmanian devils have previously demonstrated that an immune response against DFTD can be induced, and that immune-mediated tumor regression can occur. However, these trials were limited by their small sample sizes. Here, we describe the results of two DFTD immunization trials on cohorts of devils prior to their wild release as part of the Tasmanian Government's Wild Devil Recovery project. 95% of the devils developed anti-DFTD antibody responses. Given the relatively large sample sizes of the trials (N = 19 and N = 33), these responses are likely to reflect those of the general devil population. DFTD cells manipulated to express MHC-I were used as the antigenic basis of the immunizations in both trials. Although the adjuvant composition and number of immunizations differed between trials, similar anti-DFTD antibody levels were obtained. The first trial comprised DFTD cells and the adjuvant combination of ISCOMATRIX™, polyIC, and CpG with up to four immunizations given at monthly intervals. This compared to the second trial whereby two immunizations comprising DFTD cells and the adjuvant combination ISCOMATRIX™, polyICLC (Hiltonol®) and imiquimod were given a month apart, providing a shorter and, therefore, more practical protocol. Both trials incorporated a booster immunization given up to 5 months after the primary course. A key finding was that devils in the second trial responded more quickly and maintained their antibody levels for longer compared to devils in the first trial. The different adjuvant combination incorporating the RNAase resistant polyICLC and imiquimod used in the second trial is likely to be responsible. The seroconversion in the majority of devils in these anti-DFTD immunization trials was remarkable, especially as DFTD is hallmarked by its immune evasion mechanisms. Microsatellite analyzes of MHC revealed that some MHC-I microsatellites correlated to stronger immune responses. These trials signify the first step in the long-term objective of releasing devils with immunity to DFTD into the wild.

Devil facial tumor disease (DFTD) is renowned for its successful evasion of the host immune system. Down regulation of the major histocompatabilty complex class I molecule (MHC-I) on the DFTD cells is a primary mechanism of immune escape. Immunization trials on captive Tasmanian devils have previously demonstrated that an immune response against DFTD can be induced, and that immune-mediated tumor regression can occur. However, these trials were limited by their small sample sizes. Here, we describe the results of two DFTD immunization trials on cohorts of devils prior to their wild release as part of the Tasmanian Government's Wild Devil Recovery project. 95% of the devils developed anti-DFTD antibody responses. Given the relatively large sample sizes of the trials (N = 19 and N = 33), these responses are likely to reflect those of the general devil population. DFTD cells manipulated to express MHC-I were used as the antigenic basis of the immunizations in both trials. Although the adjuvant composition and number of immunizations differed between trials, similar anti-DFTD antibody levels were obtained. The first trial comprised DFTD cells and the adjuvant combination of ISCOMATRIX™, polyIC, and CpG with up to four immunizations given at monthly intervals. This compared to the second trial whereby two immunizations comprising DFTD cells and the adjuvant combination ISCOMATRIX™, polyICLC (Hiltonol®) and imiquimod were given a month apart, providing a shorter and, therefore, more practical protocol. Both trials incorporated a booster immunization given up to 5 months after the primary course. A key finding was that devils in the second trial responded more quickly and maintained their antibody levels for longer compared to devils in the first trial. The different adjuvant combination incorporating the RNAase resistant polyICLC and imiquimod used in the second trial is likely to be responsible. The seroconversion in the majority of devils in these anti-DFTD immunization trials was remarkable, especially as DFTD is ...

Context Diseases are increasingly contributing to wildlife population declines. Tasmanian devil (Sarcophilus harrisii) populations have locally declined by 82%, largely owing to the morbidity and mortality associated with two independent transmissible devil facial tumours (DFT1 and DFT2). Toxic baits are often used as a management tool for controlling vertebrate pest populations in Australia, but in other areas of the world, oral baits are also used to deliver vaccines or pharmaceuticals to wildlife. Aim Our goal was to evaluate the potential use of edible baits as vehicles for vaccine delivery to Tasmanian devils. Method We first tested bait palatability with captive devils. Bait interactions were recorded, and consumption and bait interaction behaviours were quantified. We next trialled baits containing inert capsules as potential vaccine containers in captivity. After confirming bait palatability in captivity, ground baiting was trialled at six field sites and monitored using camera traps. Finally, an automated bait dispenser was trialled at field sites to attempt to limit bait consumption by non-target species. Key results Captive devils consumed all types of placebo baits, but consumed a higher percentage of ruminant- and fish-based baits than cereal-based baits. Captive devils also consumed inert capsules inserted into placebo baits. Ground-baiting trials in the field showed that 53% of baits were removed from bait stations, with 76% of the removals occurring on the first night. Devils were suspected or confirmed to remove about 7% of baits compared with 93% by non-target species. We also evaluated an automated bait dispenser, which reduced bait removal by non-target species and resulted in over 50% of the baits being removed by devils. Conclusions This study demonstrated that captive and wild devils will accept and consume placebo versions of commercial baits. Bait dispensers or modified baits or baiting strategies are needed to increase bait uptake by devils. Implications Bait dispensers can be used at a regional scale to deliver baits to devils. These could potentially be used as vaccine-delivery vehicles to mitigate the impacts of disease on devil populations.

A combination of the dissociative anaesthetic ketamine hydrochloride and the sedative xylazine hydrochloride was used on 17 Tasmanian devils, and ketamine hydrochloride only on a further 4 animals, in the field. A dosage of 4-5 mg ketamine hydrochloride per kg body weight and 0.4-0.8 mg xylazine hydrochloride per kg body weight, administered via an intramuscular injection, resulted in short induction times (2-10 min), short recovery times (15-63 min) and 88% of the animals being unable to resist handling. The ease with which drugs were injected, and the apparent lack of adverse reactions by the devils, make this form of chemical restraint appropriate for use in the field.

Context
The value of captive breeding for recovery programs of endangered carnivorous mammals is often questioned because of low post-release survival reported for founder animals following translocation.

Aims
The aim of the present study was to test the effect of rearing method on survival and body mass of captive-raised Tasmanian devils (Sarcophilus harrisii) following release on an offshore island. We also compared the post-release diet of these devils with the diet of wild devils on mainland Tasmania, where a similar array of diet items is available.

Methods
Twenty-eight captive-raised devils were released onto the island; 19 had been raised in intensive captive-management facilities (IC) and nine in free-range (22 ha) enclosures (FRE). Survival and body-mass change were compared between IC and FRE for up to 440 days post-release. Devil diet was assessed via scat analysis.

Key results
A high proportion (96%) of the founders survived 1 year post-release. Pre-release captive-rearing method had no effect. Released devils gained an average of 14% of their original body mass, irrespective of captive-rearing method. There was very little difference in the diet of captive-reared devils released onto Maria Island relative to wild mainland devils: Tasmanian pademelon, Thylogale billardierii, was the primary food item for both.

Conclusions
The intensity of captive rearing did not affect the survival of devils released onto Maria Island. This suggests that even devils held in IC facilities retain the innate behaviour required to scavenge and hunt prey, and therefore maintain bodyweight post-release. The lack of any threatening processes on the island is also likely to have contributed to the high survival rate 2 years post-release.

Implications
Our study provided preliminary evidence that the release of captive-raised Tasmanian devils onto off-shore islands is a viable conservation action. Captive-breeding programs and captive-raised founders can play a viable and valuable role in the conservation action plans for recovery programs of endangered carnivorous mammals.

The impact of road mortality on local
populations of wildlife has rarely been quantified. In June 1991, the access
road into the northern end of the Cradle Mountain – Lake St Clair
National Park in Tasmania was widened and sealed. This occurred part-way
through an ecological study of the dasyurid carnivore guild, during which
populations were being monitored. In 17 months, the resident population of 19
eastern quolls became extinct and the devil population, of 39 individuals,
halved. Concurrently, there was a dramatic increase in the number of
road-kills. The main causal factor was probably an increase in modal speed of
about 20 km h–1 and a greater increase in maximum
speed. Measures were implemented to reduce the incidence of
vehicle/wildlife collisions. Measures directed at people included
physically slowing traffic speed (using 'slow points') and
increasing driver awareness (signs and pamphlets). Those directed at wildlife
included deterring wildlife from crossing the road in the path of approaching
vehicles (wildlife reflectors), and encouraging escape off the road (ramps
across gutters and banks, and pipes for shelter). The 'slow
points' were effective in reducing vehicle speeds by 20 km
h–1. Wildlife used the ramps and pipes. The
eastern quoll population was re-establishing within six months, and after two
years, had recovered to 50% of its former level. There was some
indication that devil populations were recovering.